The Claim
Melatonin upregulates TET2 expression in endothelial cells, which subsequently inhibits UQCRC1 methylation, thereby modifying mitochondrial protein structure to support cellular energy metabolism and prevent oxidative damage in vascular tissues.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Melatonin helps protect blood vessel cells by triggering a process that changes how certain proteins are built inside their energy-producing centers. This adjustment helps the cells generate energy more efficiently and shields them from damage caused by stress.
See the scientific wording
Melatonin increases the cellular expression of ten-eleven translocation 2 (TET2) and subsequently inhibits the methylation of ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) in endothelial cells. This epigenetic and post-translational regulation suggests that melatonin plays a direct role in modifying mitochondrial protein structure, which may be essential for maintaining cellular energy metabolism and preventing oxidative damage in vascular tissues.
What the research says
1 studyThe abstract directly states that melatonin treatment resulted in higher TET2 levels and lower methylation of UQCRC1. This provides direct observational evidence linking melatonin to these specific epigenetic and post-translational modifications in endothelial cells, establishing a clear biochemical pathway for its cellular effects.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.